| Dr Bruce Fried, MD | |
|
289 Ireland Ave, Ireland Army Community Hospital, Fort Knox, KY 40121-5111 | |
| (502) 624-9007 | |
| (502) 624-0252 |
| Full Name | Dr Bruce Fried |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 289 Ireland Ave, Fort Knox, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447337928 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | F6185 (Texas) | Primary |
| Entity Name | Concord Medical Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083630610 PECOS PAC ID: 0446296818 Enrollment ID: O20050707000531 |
News Archive
Legislation that would have allowed pharmacists not to fill some prescriptions, such as emergency contraception, because of moral or religious objections were introduced in nearly half of the state legislatures in 2006, the Washington Times reports.
A select population of patients having surgery experience what is called pain catastrophizing - an irrational thought process that leads a patient to perceive pain as worse than it actually is. Antidepressant medications reduce negative mood and might change this way of thinking, but according to a study published in the April edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, that may not be the case, at least for acute pain.
The European Collaborative Oncological Gen-‐Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
› Verified 1 days ago
| Entity Name | Concord Medical Group Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750790762 PECOS PAC ID: 7810117223 Enrollment ID: O20141007002567 |
News Archive
Legislation that would have allowed pharmacists not to fill some prescriptions, such as emergency contraception, because of moral or religious objections were introduced in nearly half of the state legislatures in 2006, the Washington Times reports.
A select population of patients having surgery experience what is called pain catastrophizing - an irrational thought process that leads a patient to perceive pain as worse than it actually is. Antidepressant medications reduce negative mood and might change this way of thinking, but according to a study published in the April edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, that may not be the case, at least for acute pain.
The European Collaborative Oncological Gen-‐Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bruce Fried, MD 1307 3rd Ave, Attn:rccs-surg, Fort Knox, KY 40121-2725 Ph: (502) 626-1128 | Dr Bruce Fried, MD 289 Ireland Ave, Ireland Army Community Hospital, Fort Knox, KY 40121-5111 Ph: (502) 624-9007 |
News Archive
Legislation that would have allowed pharmacists not to fill some prescriptions, such as emergency contraception, because of moral or religious objections were introduced in nearly half of the state legislatures in 2006, the Washington Times reports.
A select population of patients having surgery experience what is called pain catastrophizing - an irrational thought process that leads a patient to perceive pain as worse than it actually is. Antidepressant medications reduce negative mood and might change this way of thinking, but according to a study published in the April edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, that may not be the case, at least for acute pain.
The European Collaborative Oncological Gen-‐Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Notices of Allowance were recently issued by the United States Patent Office (USPTO) on patent applications filed by Thermo Fisher Scientific Inc. and licensed to RXi Pharmaceuticals encompassing small interfering RNA (siRNA) sequences targeting superoxide dismutase (SOD1), Amyloid beta (A4) precursor protein (APP), interleukin-1 receptor-associated kinase 4 (IRAK4), hepatocyte growth factor receptor (MET protooncogene) and cyclin-dependent kinase (cdk) inhibitor p27 (also known as Kip1, CDKN1B).
› Verified 1 days ago
Paul Bricker, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 871 Brule St, Fort Knox, KY 40121 Phone: 512-660-4776 | |
Clarisa Ballarta Colchado, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 433 192nd Tank Bn Road, Bldg 853, Fort Knox, KY 40121 Phone: 502-624-3149 | |
Dean Richard Giulitto, D. O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 851 Ireland Ave, Ireland Army Community Hospital, Fort Knox, KY 40121 Phone: 502-624-0220 | |
Dr. Renee L Dodge, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 289 Ireland Ave, Bldg 851 Va Clinic, Fort Knox, KY 40121 Phone: 502-624-0235 | |
Michael W. Sullivan, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1600 Spearhead Division Ave Dept 140, Fort Knox, KY 40122 Phone: 502-613-4605 Fax: 502-613-4549 | |
Dr. Edwin S Chelli, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 289 Ireland Ave, Fort Knox, KY 40121 Phone: 812-526-1135 Fax: 812-526-1768 |